Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, T-Cell × zanubrutinib × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Waldenstrom Macroglobulinemia 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia 2 B-cell Malignancies 2 Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 13 Etoposide 10 Prednisone 8 Doxorubicin 8 Whole-Body Irradiation 7 Vincristine 7 Rituximab 7 Peripheral Blood Stem Cell Transplantation 7 Melphalan 7 Brentuximab Vedotin 7 romidepsin 6 fludarabine phosphate 6 Mycophenolic Acid 6 fludarabine 5 Lenalidomide 5 Gemcitabine 5 Cytarabine 5 10-propargyl-10-deazaaminopterin 5 Tacrolimus 4 Granulocyte Colony-Stimulating Factor 4 Carmustine 4 Busulfan 4 Antilymphocyte Serum 4 pembrolizumab 3 etoposide phosphate 3 carmustine, poliferprosan 20 drug combination 3 Vorinostat 3 Sirolimus 3 Nivolumab 3 Filgrastim 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡